|
|
Determination of morphine in Yinghuan Powder by HPLC |
MA Weiping, DENG Zili, and LI Lijun. |
Department of Pharmacy, Gansu Provincial Corps Hospital, Chinese People's Armed Police Forces, Lanzhou 730050, China |
|
|
Abstract Objective To determine the content of morphine in Yinghuang Powder by HPLC. Methods The analysis was performed on a Hypersil Kromasil C 18 (150 mm×4.6 mm, 5 μm) column at room temperature with a mobile phase consisting of methyl cyanide -0.01 mol/L dibasic potassium phosphate -0.005 mol/L sodium heptanesulfonate (18∶41∶41) at a flow rate of 1 ml/min. The detection wavelength was set at 220 nm. Results Morphine showed a good linear correlation within the range 1.5~30.0 μg/ml ( r =0.9999),The average recovery and RSD were 99.16%and 1.17%, respectively. Conclusions This method is simple, accurate and repeatable, which can be used for quality control of Yinghuan Powder.
|
Received: 27 December 2011
|
|
|
|
|
[1] |
周建衡, 曾建伟. HPLC法测定强力枇杷露(煎膏剂) 中吗啡的含量[J]. 中医药导报,2008,14(9):71-72.[2]霍红,李璐,蔡航,等. 高效液相色谱法测定黄芪桂枝五物颗粒中黄芪甲苷的含量[J]. 武警医学, 2011, 22 (12):1073-1077.[3]邱洪,王宝佳, 杨立勇, 等.固相萃取- 高效液相色谱法测定枇杷止咳胶囊中吗啡的含量[J]. 中国药房, 2007, 18( 9): 686-687.[4]刘绪林,付蕾,刘磊,等.离子对色谱法测定咳速停颗粒中吗啡的含量[J]. 中国医院药学杂志, 2008, 28(6): 421-423.[5]国家药典委员会. 中华人民共和国药典(一部)[S]. 北京:化学工业出版社, 2010:346-347.[6]刘晓东,闫明,黄毅, 等. HPLC 法测定温肾苏拉甫片中吗啡的含量[J]. 石河子大学学报( 自然科学版), 2008, 26 (2):161-163.[7]刘克江. HPLC法测定复方甘草口服溶液中吗啡的含量[J]. 天津药学, 2007, 19(1):20-21.[8]崔兰贵,白淑芳,王晓东,等. 高效液相色谱法测定肝得治胶囊中五味子醇甲的含量[J]. 武警医学, 2008, 19 (2):168-169.
|
[1] |
周建衡, 曾建伟. HPLC法测定强力枇杷露(煎膏剂) 中吗啡的含量[J]. 中医药导报,2008,14(9):71-72.[2]霍红,李璐,蔡航,等. 高效液相色谱法测定黄芪桂枝五物颗粒中黄芪甲苷的含量[J]. 武警医学, 2011, 22 (12):1073-1077.[3]邱洪,王宝佳, 杨立勇, 等.固相萃取- 高效液相色谱法测定枇杷止咳胶囊中吗啡的含量[J]. 中国药房, 2007, 18( 9): 686-687.[4]刘绪林,付蕾,刘磊,等.离子对色谱法测定咳速停颗粒中吗啡的含量[J]. 中国医院药学杂志, 2008, 28(6): 421-423.[5]国家药典委员会. 中华人民共和国药典(一部)[S]. 北京:化学工业出版社, 2010:346-347.[6]刘晓东,闫明,黄毅, 等. HPLC 法测定温肾苏拉甫片中吗啡的含量[J]. 石河子大学学报( 自然科学版), 2008, 26 (2):161-163.[7]刘克江. HPLC法测定复方甘草口服溶液中吗啡的含量[J]. 天津药学, 2007, 19(1):20-21.[8]崔兰贵,白淑芳,王晓东,等. 高效液相色谱法测定肝得治胶囊中五味子醇甲的含量[J]. 武警医学, 2008, 19 (2):168-169.
|
|
|
|